MFM-223
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1408
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1913690 PMID:20164919 PMID:22414580 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:27397505 PMID:28196595 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Female |
MFM223 |
|
|
BTO:BTO_0001961, CLO:CLO_0007695, EFO:EFO_0006649, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:943, BioSample:SAMN03473045, BioSample:SAMN03473592, cancercelllines:CVCL_1408, Cell_Model_Passport:SIDM00332, ChEMBL-Cells:CHEMBL3308115, ChEMBL-Targets:CHEMBL1075504, Cosmic:910948, Cosmic:2165000, Cosmic-CLP:910948, DepMap:ACH-001819, DSMZ:ACC-422, DSMZCellDive:ACC-422, ECACC:98050130, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910948, GEO:GSM344380, GEO:GSM344430, GEO:GSM595616, GEO:GSM783967, GEO:GSM1172985, GEO:GSM1670102, IARC_TP53:21497, LINCS_LDP:LCL-1318, PharmacoDB:MFM223_923_2019, PRIDE:PXD000309, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_1408, PubChem_Cell_line:CVCL_1408, Wikidata:Q54905396 |
|
|
CVCL_1408 |
2026-09-05 11:11:39 |
11 |
MHH-PREB-1
Resource Report
Resource Website
|
RRID:CVCL_1413
|
Homo sapiens (Human)
|
B-cell non-Hodgkin lymphoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9067587 PMID:20164919 PMID:20215515 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
MHHPREB1 |
|
|
CLO:CLO_0007720, EFO:EFO_0002235, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioSample:SAMN03471645, BioSample:SAMN03473315, cancercelllines:CVCL_1413, Cell_Model_Passport:SIDM00388, ChEMBL-Cells:CHEMBL3308334, ChEMBL-Targets:CHEMBL2366127, Cosmic:908136, Cosmic:2276316, Cosmic:2491097, Cosmic-CLP:908136, DepMap:ACH-002272, DSMZ:ACC-354, DSMZCellDive:ACC-354, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:908136, GEO:GSM1670108, IARC_TP53:21503, IGRhCellID:MHHPREB1, LINCS_LDP:LCL-1140, PharmacoDB:MHHPREB1_930_2019, PRIDE:PXD030304, Progenetix:CVCL_1413, PubChem_Cell_line:CVCL_1413, Wikidata:Q54905548 |
|
|
CVCL_1413 |
2026-09-05 11:11:42 |
0 |
MHH-NB-11
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-157, RRID:CVCL_1412
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3218965 PMID:11668190 PMID:20164919 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
MHH-NB11, MHHNB11 |
DSMZ |
ACC-157 |
CLO:CLO_0007719, EFO:EFO_0006651, CLDB:cl3479, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:546, BioSample:SAMN03473088, BioSample:SAMN10988427, cancercelllines:CVCL_1412, Cell_Model_Passport:SIDM00387, ChEMBL-Cells:CHEMBL3308310, ChEMBL-Targets:CHEMBL2366185, Cosmic:908135, Cosmic:2485948, Cosmic-CLP:908135, DepMap:ACH-000078, DSMZ:ACC-157, DSMZCellDive:ACC-157, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:908135, GEO:GSM887319, GEO:GSM888395, GEO:GSM1366409, GEO:GSM1670107, GEO:GSM3145573, GEO:GSM3145723, IARC_TP53:21502, LiGeA:CCLE_041, LINCS_LDP:LCL-1975, PharmacoDB:MHHNB11_929_2019, PRIDE:PXD030304, Progenetix:CVCL_1412, PubChem_Cell_line:CVCL_1412, Wikidata:Q54905545 |
|
|
CVCL_1412 |
2026-09-05 11:11:42 |
5 |
MHH-CALL-4
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1410
|
Homo sapiens (Human)
|
Childhood B acute lymphoblastic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:15843827 PMID:16408098 PMID:20164919 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35354797 PMID:35839778
|
Cancer cell line
|
Male |
MHH-CALL4, MHHCALL4 |
|
|
CLO:CLO_0007717, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473351, BioSample:SAMN10988510, cancercelllines:CVCL_1410, Cell_Model_Passport:SIDM00376, Cosmic:908133, Cosmic:1012090, Cosmic:1278370, Cosmic:1524804, Cosmic:2759716, Cosmic-CLP:908133, DepMap:ACH-000156, DSMZ:ACC-337, DSMZCellDive:ACC-337, EGA:EGAS00001000978, GEO:GSM887317, GEO:GSM888393, GEO:GSM1670105, GEO:GSM5137726, IARC_TP53:21500, LiGeA:CCLE_066, PharmacoDB:MHHCALL4_927_2019, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_1410, Wikidata:Q54905538 |
|
|
CVCL_1410 |
2026-09-05 11:11:42 |
4 |
MHH-ES-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1411
|
Homo sapiens (Human)
|
Ewing sarcoma
|
Population: Caucasian., Part of: Ewing Sarcoma Cell Line Atlas (ESCLA)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:22142829 PMID:22460905 PMID:25223734 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778 PMID:36476851
|
Cancer cell line
|
Male |
MHH-ES1, MHHES1 |
|
|
CLO:CLO_0007718, EFO:EFO_0006650, CLDB:cl3478, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:185, BioSample:SAMN03471911, BioSample:SAMN03473362, BioSample:SAMN10988548, cancercelllines:CVCL_1411, Cell_Model_Passport:SIDM00386, ChEMBL-Cells:CHEMBL3308762, ChEMBL-Targets:CHEMBL1075505, CLS:300136, Cosmic:908134, Cosmic:1718436, Cosmic:2250463, Cosmic-CLP:908134, DepMap:ACH-000391, DSMZ:ACC-167, DSMZCellDive:ACC-167, EGA:EGAS00001000610, GDSC:908134, GEO:GSM887318, GEO:GSM888394, GEO:GSM1670106, GEO:GSM5359670, GEO:GSM5359671, GEO:GSM5359672, GEO:GSM5359673, GEO:GSM5359674, GEO:GSM5359675, GEO:GSM5362922, GEO:GSM5362923, GEO:GSM5362924, GEO:GSM5362925, GEO:GSM5362926, GEO:GSM5362927, GEO:GSM5363976, GEO:GSM5363977, GEO:GSM5363978, GEO:GSM5363979, GEO:GSM5363980, IARC_TP53:21501, LiGeA:CCLE_341, LINCS_LDP:LCL-1454, PharmacoDB:MHHES1_928_2019, PRIDE:PXD030304, Progenetix:CVCL_1411, PubChem_Cell_line:CVCL_1411, Wikidata:Q54905539 |
|
|
CVCL_1411 |
2026-09-05 11:11:42 |
7 |
MHH-CALL-2
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-341, RRID:CVCL_1409
|
Homo sapiens (Human)
|
Childhood B acute lymphoblastic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9067587 PMID:15843827 PMID:16408098 PMID:20164919 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35354797
|
Cancer cell line
|
Female |
Mhh-Call 2, MHH-CALL2, MHHCALL2 |
DSMZ |
ACC-341 |
CLO:CLO_0007715, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473355, BioSample:SAMN10988567, cancercelllines:CVCL_1409, Cell_Model_Passport:SIDM00331, ChEMBL-Cells:CHEMBL3308333, ChEMBL-Targets:CHEMBL2366286, Cosmic:908132, Cosmic:1012089, Cosmic:1130251, Cosmic:1524803, Cosmic:1943387, Cosmic:2491071, Cosmic-CLP:908132, DepMap:ACH-000020, DSMZ:ACC-341, DSMZCellDive:ACC-341, EGA:EGAS00001000978, GDSC:908132, GEO:GSM236789, GEO:GSM236825, GEO:GSM887315, GEO:GSM888391, GEO:GSM931335, GEO:GSM1670104, GEO:GSM5137724, IARC_TP53:21499, LiGeA:CCLE_318, LINCS_LDP:LCL-1009, PharmacoDB:MHHCALL2_925_2019, PRIDE:PXD023662, Progenetix:CVCL_1409, PubChem_Cell_line:CVCL_1409, Wikidata:Q54905536 |
|
|
CVCL_1409 |
2026-09-05 11:11:42 |
2 |
MIA PaCa-2
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0428
|
Homo sapiens (Human)
|
Pancreatic undifferentiated carcinoma
|
Caution: Additional TP53 mutation in c.818G>A indicated incorrectly in PubMed=1630814., Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:832918 PMID:1630814 PMID:1764370 PMID:7809022 PMID:7961102 PMID:8026879 PMID:8194712 PMID:9290701 PMID:10027410 PMID:11115575 PMID:11169957 PMID:11169959 PMID:11787853 PMID:12068308 PMID:12692724 PMID:14695172 PMID:15770730 PMID:16912165 PMID:17254797 PMID:18298655 PMID:18380791 PMID:18575732 PMID:19077451 PMID:19188929 PMID:19904223 PMID:20037478 PMID:20164919 PMID:20215515 PMID:20418756 PMID:21607521 PMID:22460905 PMID:22585861 PMID:23386380 PMID:25167228 PMID:25485619 PMID:25485960 PMID:25877200 PMID:25984343 PMID:26216984 PMID:26884312 PMID:27067801 PMID:27259358 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31037374 PMID:31068700 PMID:31978347 PMID:32782605 PMID:34207840 PMID:35839778
|
Cancer cell line
|
Male |
MIA-PaCa-2, MIA-PACA-2, MIA-Pa-Ca-2, MIA Paca2, MIA PaCa2, MiaPaCa-2, MIAPACA-2, MiaPaca.2, MiaPaCa2, Miapaca2, MIAPaCa2, MIAPACA2, Mia PACA 2, MIAPaCa-2, PaCa2, MiaPaCa, MIAMI Pancreatic Carcinoma-2 |
|
|
BTO:BTO_0002137, CLO:CLO_0007726, CLO:CLO_0050101, EFO:EFO_0002236, MCCL:MCC:0000325, CLDB:cl3480, CLDB:cl3481, CLDB:cl3482, AddexBio:C0018002/59, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3263, ArrayExpress:E-MTAB-3610, ATCC:CRL-1420, ATCC:CRM-CRL-1420, BCRC:60139, BCRJ:0174, BioGRID_ORCS_Cell_line:544, BioSample:SAMN01821579, BioSample:SAMN01821700, BioSample:SAMN03472131, BioSample:SAMN10988205, cancercelllines:CVCL_0428, CCRID:3101HUMSCSP568, CCRID:4201HUM-CCTCC00255, CCTCC:GDC0255, Cell_Model_Passport:SIDM00505, CGH-DB:321-1, CGH-DB:9374-4, ChEMBL-Cells:CHEMBL3308500, ChEMBL-Targets:CHEMBL614725, CLS:300438, Cosmic:707249, Cosmic:710861, Cosmic:719677, Cosmic:724644, Cosmic:724870, Cosmic:730532, Cosmic:808172, Cosmic:868243, Cosmic:872996, Cosmic:913313, Cosmic:918056, Cosmic:922249, Cosmic:923170, Cosmic:932520, Cosmic:947399, Cosmic:948373, Cosmic:948731, Cosmic:949234, Cosmic:968107, Cosmic:1006368, Cosmic:1066202, Cosmic:1108337, Cosmic:1198208, Cosmic:1299302, Cosmic:1320461, Cosmic:1366278, Cosmic:1477431, Cosmic:1534318, Cosmic:1571779, Cosmic:1609545, Cosmic:1644314, Cosmic:1995507, Cosmic:2434084, Cosmic:2664042, Cosmic:2668287, Cosmic:2755950, Cosmic-CLP:724870, DepMap:ACH-000601, DSMZ:ACC-733, DSMZCellDive:ACC-733, ECACC:85062806, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10488-107B2, FCS-free:216-2-440-1-3-6, GDSC:724870, GEO:GSM206526, GEO:GSM244425, GEO:GSM621895, GEO:GSM784703, GEO:GSM887320, GEO:GSM888396, GEO:GSM1024404, GEO:GSM1374677, GEO:GSM1374678, GEO:GSM1374679, GEO:GSM1435696, GEO:GSM1435697, GEO:GSM1435698, GEO:GSM1588612, GEO:GSM1588624, GEO:GSM1670109, GEO:GSM5481591, GEO:GSM5481592, GEO:GSM5481593, GEO:GSM5481594, IARC_TP53:316, IGRhCellID:MIAPaCa, IZSLER:BS TCL 42, JCRB:JCRB0070, KCLB:21420, LiGeA:CCLE_231, LINCS_LDP:LCL-1738, Lonza:751, MetaboLights:MTBLS812, NCBI_Iran:C459, PharmacoDB:MIAPaCa2_931_2019, PRIDE:PXD001260, PRIDE:PXD003198, PRIDE:PXD030304, Progenetix:CVCL_0428, PubChem_Cell_line:CVCL_0428, RCB:RCB2094, SKY/M-FISH/CGH:1996, TKG:TKG 0227, Wikidata:Q54905679 |
|
|
CVCL_0428 |
2026-09-05 11:11:45 |
1066 |
MJ
Resource Report
Resource Website
1+ mentions
|
ATCC Cat# CRL-8294, RRID:CVCL_1414
|
Homo sapiens (Human)
|
Primary cutaneous T-cell non-Hodgkin lymphoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:6604130 PMID:7662981 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25355872 PMID:26589293 PMID:30285677 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Male |
G11 |
ATCC |
CRL-8294 |
CLO:CLO_0007731, EFO:EFO_0002237, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ATCC:CRL-8294, BCRC:60543, BioSample:SAMN03471200, BioSample:SAMN10987950, cancercelllines:CVCL_1414, Cell_Model_Passport:SIDM01692, Cosmic:908137, DepMap:ACH-000077, GEO:GSM887322, GEO:GSM888398, IARC_TP53:21504, IGRhCellID:MJ, LiGeA:CCLE_874, LINCS_LDP:LCL-1142, PharmacoDB:MJ_933_2019, Progenetix:CVCL_1414, Wikidata:Q54905784 |
|
|
CVCL_1414 |
2026-09-05 11:11:48 |
4 |
MKN1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1415
|
Homo sapiens (Human)
|
Gastric adenosquamous carcinoma
|
Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:758928 PMID:1370612 PMID:1778766 PMID:1933850 PMID:6862145 PMID:9290701 PMID:11107048 PMID:15723654 PMID:15767549 PMID:15900046 PMID:20164919 PMID:20215515 PMID:22336246 PMID:22460905 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29435981 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:32847597 PMID:34331011
|
Cancer cell line
|
Male |
MKN-1, MKN 1 |
|
|
BTO:BTO_0002384, CLO:CLO_0050804, EFO:EFO_0002830, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473129, BioSample:SAMN10987827, cancercelllines:CVCL_1415, Cell_Model_Passport:SIDM00271, CGH-DB:117-1, CGH-DB:9019-4, ChEMBL-Cells:CHEMBL3307492, ChEMBL-Targets:CHEMBL614352, Cosmic:733174, Cosmic:801337, Cosmic:848145, Cosmic:848379, Cosmic:887252, Cosmic:888824, Cosmic:897532, Cosmic:908138, Cosmic:922692, Cosmic:926111, Cosmic:1007600, Cosmic:1090459, Cosmic:1093296, Cosmic:1187282, Cosmic:1223586, Cosmic:1436023, Cosmic:1482076, Cosmic:1627263, Cosmic:1995508, Cosmic:2443801, Cosmic:2484957, Cosmic:2807632, Cosmic-CLP:908138, DepMap:ACH-000351, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10614-108G2, GDSC:908138, GEO:GSM552363, GEO:GSM562394, GEO:GSM827531, GEO:GSM844606, GEO:GSM887323, GEO:GSM888399, GEO:GSM1374680, GEO:GSM1670111, IARC_TP53:998, JCRB:JCRB0252, KCLB:80101, LiGeA:CCLE_128, LINCS_LDP:LCL-1917, Lonza:1374, PharmacoDB:MKN1_936_2019, Progenetix:CVCL_1415, PubChem_Cell_line:CVCL_1415, RCB:RCB1003, Wikidata:Q54905820 |
|
|
CVCL_1415 |
2026-09-05 11:11:49 |
22 |
MKN45
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0434
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Caution: Was indicated not to have a TP53 mutation in PubMed=1370612 and PubMed=15900046., Characteristics: MET-amplified, contains 12-13 copies of the gene (PubMed=29435981)., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:758928 PMID:1370612 PMID:1486568 PMID:1778766 PMID:1846553 PMID:1933850 PMID:2061947 PMID:2105279 PMID:3962675 PMID:3986962 PMID:6862145 PMID:9023415 PMID:9247707 PMID:9290701 PMID:9665481 PMID:11107048 PMID:11314020 PMID:11668190 PMID:15723654 PMID:15767549 PMID:15900046 PMID:15901131 PMID:18804159 PMID:20164919 PMID:20215515 PMID:22336246 PMID:22460905 PMID:22531121 PMID:23671654 PMID:24587255 PMID:24807215 PMID:25343454 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29435981 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
MKN-45, MKN 45 |
|
|
BTO:BTO_0001225, CLO:CLO_0007733, CLO:CLO_0050797, EFO:EFO_0002832, MCCL:MCC:0000329, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:404, BioSample:SAMN03473237, BioSample:SAMN03473585, BioSample:SAMN10988555, cancercelllines:CVCL_0434, CCRID:1101HUM-PUMC000229, CCTCC:GDC0220, Cell_Model_Passport:SIDM00247, CGH-DB:120-1, CGH-DB:9022-4, ChEMBL-Cells:CHEMBL3307603, ChEMBL-Targets:CHEMBL614354, CLS:300489, Cosmic:685596, Cosmic:801339, Cosmic:848147, Cosmic:848373, Cosmic:873711, Cosmic:877042, Cosmic:887256, Cosmic:888827, Cosmic:897535, Cosmic:918497, Cosmic:922696, Cosmic:925340, Cosmic:926114, Cosmic:968349, Cosmic:983727, Cosmic:1001651, Cosmic:1001655, Cosmic:1007602, Cosmic:1090461, Cosmic:1093299, Cosmic:1187283, Cosmic:1223589, Cosmic:1329185, Cosmic:1436026, Cosmic:1460707, Cosmic:1518241, Cosmic:1518255, Cosmic:1582430, Cosmic:1627265, Cosmic:1995510, Cosmic:2036663, Cosmic:2807633, Cosmic:2823225, Cosmic-CLP:925340, DepMap:ACH-000356, DSMZ:ACC-409, DSMZCellDive:ACC-409, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10612-108F9, GDSC:925340, GEO:GSM552364, GEO:GSM562395, GEO:GSM618013, GEO:GSM618014, GEO:GSM618015, GEO:GSM618016, GEO:GSM827532, GEO:GSM828836, GEO:GSM844607, GEO:GSM887324, GEO:GSM888400, GEO:GSM1374681, GEO:GSM1670113, IARC_TP53:21633, IARC_TP53:30213, IBRC:C10137, JCRB:JCRB0254, KCLB:80103, LiGeA:CCLE_725, LINCS_LDP:LCL-1535, NCBI_Iran:C615, PharmacoDB:MKN45_938_2019, PRIDE:PXD030304, Progenetix:CVCL_0434, PubChem_Cell_line:CVCL_0434, RCB:RCB1001, Wikidata:Q28473066 |
|
|
CVCL_0434 |
2026-09-05 11:11:49 |
974 |
MKN28
Resource Report
Resource Website
10+ mentions
Contaminated Discontinued Discontinued Discontinued Discontinued
|
RRID:CVCL_1416
|
Homo sapiens (Human)
|
Gastric tubular adenocarcinoma
|
Population: Japanese., Part of: JFCR45 cancer cell line panel., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a MKN74 derivative (PubMed=20143388)..
|
PMID:758928 PMID:1370612 PMID:1933850 PMID:3962675 PMID:3986962 PMID:6862145 PMID:9023415 PMID:9290701 PMID:11107048 PMID:11314020 PMID:15723654 PMID:15767549 PMID:15900046 PMID:15901131 PMID:20143388 PMID:20164919 PMID:22336246 PMID:22490663 PMID:23671654 PMID:25960936 PMID:27397505 PMID:29435981 PMID:29717028 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Male |
MKN-28, MKN 28 |
|
|
BTO:BTO_0002381, CLO:CLO_0037142, EFO:EFO_0002831, ABM:T9192, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:944, BioSample:SAMN03151847, cancercelllines:CVCL_1416, Cell_Model_Passport:SIDM00260, CGH-DB:119-1, CGH-DB:9021-4, ChEMBL-Cells:CHEMBL3307602, ChEMBL-Targets:CHEMBL614353, Cosmic:801338, Cosmic:848146, Cosmic:848371, Cosmic:873710, Cosmic:875905, Cosmic:877041, Cosmic:887249, Cosmic:888826, Cosmic:897534, Cosmic:908139, Cosmic:918496, Cosmic:922694, Cosmic:926113, Cosmic:968348, Cosmic:983726, Cosmic:1066230, Cosmic:1067208, Cosmic:1090460, Cosmic:1093298, Cosmic:1223588, Cosmic:1436025, Cosmic:1460710, Cosmic:1482081, Cosmic:1627264, Cosmic:1995509, Cosmic:2036660, Cosmic:2069778, Cosmic:2823226, Cosmic-CLP:908139, DepMap:ACH-002161, EGA:EGAS00001000978, GDSC:908139, GEO:GSM562396, GEO:GSM1670112, IARC_TP53:972, IARC_TP53:21505, JCRB:FDSC0011, JCRB:JCRB0253, JCRB:NIHS0324, JCRB:NIHS0325, KCLB:80102, LINCS_LDP:LCL-1922, PharmacoDB:MKN28_937_2019, PRIDE:PXD030304, Progenetix:CVCL_1416, PubChem_Cell_line:CVCL_1416, RCB:RCB1000, Wikidata:Q54905823 |
cvcl_2791 |
|
CVCL_1416 |
2026-09-05 11:11:49 |
17 |
MDA-MB-468
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0419
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: African American., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: EGFR genetic alteration cell panel (ATCC TCP-1027)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:730202 PMID:1961733 PMID:3518877 PMID:9671407 PMID:10969801 PMID:11414198 PMID:12353263 PMID:12800145 PMID:15153330 PMID:15677628 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18262045 PMID:18516279 PMID:19582160 PMID:19593635 PMID:20070913 PMID:20164919 PMID:21778573 PMID:22384151 PMID:22460905 PMID:22585861 PMID:22628656 PMID:23151021 PMID:23601657 PMID:23856246 PMID:24094812 PMID:24162158 PMID:24176112 PMID:24279929 PMID:25485619 PMID:25699542 PMID:25877200 PMID:25892236 PMID:25960936 PMID:26589293 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:28287265 PMID:28889351 PMID:29273624 PMID:30613774 PMID:30787054 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:32576280 PMID:34703030 PMID:35839778 PMID:38861359 PMID:40300663
|
Cancer cell line
|
Female |
MDA-MB 468, MDA-MB468, MDAMB468, MDA-468, MDA468, MB468, MD Anderson-Metastatic Breast-468 |
|
|
BTO:BTO_0001570, CLO:CLO_0007641, EFO:EFO_0001216, MCCL:MCC:0000316, CLDB:cl4973, AddexBio:C0006003/4673, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-6647, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-132, BCRJ:0166, BioGRID_ORCS_Cell_line:551, BioSample:SAMN03473056, BioSample:SAMN05292454, BioSample:SAMN10988340, cancercelllines:CVCL_0419, CCRID:1101HUM-PUMC000249, CCRID:3101HUMTCHu136, Cell_Model_Passport:SIDM00628, ChEMBL-Cells:CHEMBL3308424, ChEMBL-Targets:CHEMBL614335, CLS:300279, Cosmic:809241, Cosmic:850823, Cosmic:871149, Cosmic:877448, Cosmic:897427, Cosmic:904384, Cosmic:908123, Cosmic:923061, Cosmic:934530, Cosmic:949192, Cosmic:991327, Cosmic:997921, Cosmic:1000125, Cosmic:1010920, Cosmic:1017167, Cosmic:1018467, Cosmic:1044224, Cosmic:1046929, Cosmic:1047691, Cosmic:1136363, Cosmic:1152526, Cosmic:1176635, Cosmic:1287918, Cosmic:1289402, Cosmic:1305384, Cosmic:1309004, Cosmic:1477427, Cosmic:1523775, Cosmic:1524344, Cosmic:1571795, Cosmic:1603223, Cosmic:1609465, Cosmic:1998490, Cosmic:2009514, Cosmic:2036673, Cosmic:2164999, Cosmic:2301533, Cosmic:2318380, Cosmic:2361357, Cosmic:2668276, Cosmic-CLP:908123, DepMap:ACH-000849, DSMZ:ACC-738, DSMZCellDive:ACC-738, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:908123, GEO:GSE184543, GEO:GSM75169, GEO:GSM185095, GEO:GSM185096, GEO:GSM217591, GEO:GSM219929, GEO:GSM344356, GEO:GSM344406, GEO:GSM350502, GEO:GSM388214, GEO:GSM421880, GEO:GSM459714, GEO:GSM459722, GEO:GSM466357, GEO:GSM783955, GEO:GSM847418, GEO:GSM847497, GEO:GSM887301, GEO:GSM888376, GEO:GSM1008911, GEO:GSM1053727, GEO:GSM1172984, GEO:GSM1214565, GEO:GSM1238123, GEO:GSM1374663, GEO:GSM1374664, GEO:GSM1374665, GEO:GSM1401650, GEO:GSM1556177, GEO:GSM1556178, GEO:GSM1556179, GEO:GSM1556180, GEO:GSM1556181, GEO:GSM1661984, GEO:GSM1670087, GEO:GSM1833629, GEO:GSM2124671, GEO:GSM2258884, GEO:GSM2258885, GEO:GSM2258886, GEO:GSM2258887, GEO:GSM2258888, GEO:GSM2258889, GEO:GSM2258890, GEO:GSM2258891, GEO:GSM2258892, GEO:GSM2258893, GEO:GSM2258894, GEO:GSM2258895, GEO:GSM2258896, GEO:GSM2258897, GEO:GSM2258898, GEO:GSM2258899, GEO:GSM2258900, GEO:GSM2258901, GEO:GSM2258941, GEO:GSM2258942, GEO:GSM2258943, IARC_TP53:94, IBRC:C10095, ICLC:HTL99024, KCB:KCB 2011114YJ, LiGeA:CCLE_336, LINCS_HMS:50335, LINCS_LDP:LCL-1471, Lonza:809, NCBI_Iran:C208, NCI-DTP:MDA-MB-468, PharmacoDB:MDAMB468_907_2019, PRIDE:PXD001680, PRIDE:PXD005295, PRIDE:PXD008222, PRIDE:PXD022325, PRIDE:PXD030304, Progenetix:CVCL_0419, PubChem_Cell_line:CVCL_0419, SLKBase:3578, TOKU-E:2401, TOKU-E:3604, Ubigene:YC-D009, Wikidata:Q16880225 |
|
|
CVCL_0419 |
2026-09-05 11:11:23 |
3971 |
MDA-MB-453
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0418
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: Caucasian., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:730202 PMID:1961733 PMID:3518877 PMID:9671407 PMID:9815641 PMID:10969801 PMID:11687795 PMID:11789735 PMID:12353263 PMID:12800145 PMID:16142302 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18516279 PMID:19582160 PMID:19593635 PMID:20164919 PMID:20215515 PMID:21378333 PMID:22121396 PMID:22414580 PMID:22460905 PMID:22585861 PMID:22719059 PMID:23601657 PMID:24094812 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25984343 PMID:26218769 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28889351 PMID:30787054 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
MDA-MB 453, MDA MB 453, MDA-MB453, MDAMB453, MDA-453, MDA453, MD Anderson-Metastatic Breast-453 |
|
|
BTO:BTO_0001908, CLO:CLO_0007640, CLO:CLO_0050867, EFO:EFO_0001215, MCCL:MCC:0000315, CLDB:cl3411, CLDB:cl7187, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-131, BCRC:60429, BioGRID_ORCS_Cell_line:552, BioSample:SAMN01821576, BioSample:SAMN01821647, BioSample:SAMN03472899, BioSample:SAMN10988263, cancercelllines:CVCL_0418, CCRID:1101HUM-PUMC000016, CCRID:3101HUMSCSP5044, CCRID:3101HUMTCHu233, Cell_Model_Passport:SIDM00272, ChEMBL-Cells:CHEMBL3307596, ChEMBL-Targets:CHEMBL614334, CLS:305042, Cosmic:687497, Cosmic:871157, Cosmic:897426, Cosmic:904383, Cosmic:908122, Cosmic:923060, Cosmic:934529, Cosmic:979712, Cosmic:991326, Cosmic:997920, Cosmic:1010927, Cosmic:1018468, Cosmic:1027056, Cosmic:1044223, Cosmic:1046931, Cosmic:1047694, Cosmic:1129656, Cosmic:1136356, Cosmic:1152522, Cosmic:1176651, Cosmic:1287911, Cosmic:1289401, Cosmic:1308995, Cosmic:1434956, Cosmic:1524345, Cosmic:1601924, Cosmic:1603222, Cosmic:1609457, Cosmic:2165012, Cosmic:2301532, Cosmic:2318375, Cosmic:2564832, Cosmic:2820307, Cosmic-CLP:908122, DepMap:ACH-000910, DSMZ:ACC-65, DSMZCellDive:ACC-65, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, FANTOM5_SSTAR:10419-106C5, GDSC:908122, GEO:GSM813, GEO:GSM115117, GEO:GSM217590, GEO:GSM219956, GEO:GSM274656, GEO:GSM344355, GEO:GSM344405, GEO:GSM350530, GEO:GSM421879, GEO:GSM481307, GEO:GSM783928, GEO:GSM844602, GEO:GSM847417, GEO:GSM887300, GEO:GSM888375, GEO:GSM1008910, GEO:GSM1053710, GEO:GSM1172983, GEO:GSM1264071, GEO:GSM1264075, GEO:GSM1264113, GEO:GSM1264117, GEO:GSM1374660, GEO:GSM1374661, GEO:GSM1374662, GEO:GSM1384316, GEO:GSM1401667, GEO:GSM1421431, GEO:GSM1661983, GEO:GSM1664568, GEO:GSM1670086, IARC_TP53:762, IARC_TP53:21146, IARC_TP53:26995, ICLC:HTL01013, IGRhCellID:MDAMB453, IZSLER:BS TCL 247, KCLB:30131, LiGeA:CCLE_768, LINCS_HMS:50334, LINCS_LDP:LCL-1485, Lonza:837, NCBI_Iran:C214, PharmacoDB:MDAMB453_906_2019, PRIDE:PXD000309, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_0418, PubChem_Cell_line:CVCL_0418, RCB:RCB1192, SLKBase:3613, Wikidata:Q54904642 |
|
|
CVCL_0418 |
2026-09-05 11:11:23 |
1504 |
Mel Ho
Resource Report
Resource Website
1+ mentions
Misidentified/Contaminated
|
RRID:CVCL_1402
|
Homo sapiens (Human)
|
Melanoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (Cellosaurus=CVCL_1868) but it does not have the same STR profile (PubMed=10508494; PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line..
|
PMID:6895502 PMID:10508494 PMID:11668190 PMID:20143388 PMID:20164919 PMID:22170099 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
MEL HO, MEL-HO, MEL-Ho, Mel-HO, MelHo, MELHO, Ho |
|
|
BTO:BTO_0001587, CLO:CLO_0007675, EFO:EFO_0006647, CLDB:cl3439, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:549, BioSample:SAMN03152032, BioSample:SAMN03473130, BioSample:SAMN03473505, BioSample:SAMN10988268, cancercelllines:CVCL_1402, Cell_Model_Passport:SIDM00337, ChEMBL-Cells:CHEMBL3308798, ChEMBL-Targets:CHEMBL1075500, Cosmic:908124, Cosmic:1995504, Cosmic-CLP:908124, DepMap:ACH-000450, DSMZ:ACC-62, DSMZCellDive:ACC-62, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:908124, GEO:GSM887308, GEO:GSM888384, GEO:GSM1670094, IARC_TP53:21492, LiGeA:CCLE_006, LINCS_LDP:LCL-1251, PharmacoDB:MELHO_914_2019, PRIDE:PXD030304, Progenetix:CVCL_1402, PubChem_Cell_line:CVCL_1402, Wikidata:Q54905059 |
|
|
CVCL_1402 |
2026-09-05 11:11:33 |
5 |
MPP 89
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1427
|
Homo sapiens (Human)
|
Pleural epithelioid mesothelioma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10232421 PMID:20164919 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
MPP-89, MPP89 |
|
|
CLO:CLO_0007858, CLO:CLO_0037115, CLDB:cl5400, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN10988144, cancercelllines:CVCL_1427, Cell_Model_Passport:SIDM00222, ChEMBL-Cells:CHEMBL3308241, ChEMBL-Targets:CHEMBL2366357, Cosmic:908150, Cosmic:1995512, Cosmic-CLP:908150, DepMap:ACH-000319, EGA:EGAS00001000978, GDSC:908150, GEO:GSM887341, GEO:GSM888417, GEO:GSM1670132, ICLC:HTL00012, LiGeA:CCLE_327, LINCS_LDP:LCL-1229, PharmacoDB:MPP89_964_2019, PRIDE:PXD030304, Progenetix:CVCL_1427, PubChem_Cell_line:CVCL_1427, Wikidata:Q54906515 |
|
|
CVCL_1427 |
2026-09-05 11:12:08 |
4 |
MRK-nu-1
Resource Report
Resource Website
1+ mentions
Possibly Discontinued
|
RRID:CVCL_1428
|
Homo sapiens (Human)
|
Breast carcinoma
|
Characteristics: Established from the ascitic cells from BALB/c nu/nu mice injected intraperitoneal with the parent tumoral cells., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:518958 PMID:9290701 PMID:15900046 PMID:20164919 PMID:20215515 PMID:27397505 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Female |
MRK-NU-1, MRK-nu-I, Mrk-nu1, MRKnu-1, MRKnu1, MRKNU1 |
|
|
BTO:BTO_0003679, CLO:CLO_0009914, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03471641, cancercelllines:CVCL_1428, Cell_Model_Passport:SIDM00562, ChEMBL-Cells:CHEMBL3308550, ChEMBL-Targets:CHEMBL2366325, Cosmic:908151, Cosmic-CLP:908151, DepMap:ACH-002163, EGA:EGAS00001000978, GDSC:908151, GEO:GSM827236, GEO:GSM1670133, IARC_TP53:21516, JCRB:JCRB0616, JCRB:JCRB0628, LINCS_LDP:LCL-1487, PharmacoDB:MRKnu1_965_2019, PRIDE:PXD030304, Progenetix:CVCL_1428, PubChem_Cell_line:CVCL_1428, Wikidata:Q54906738 |
|
|
CVCL_1428 |
2026-09-05 11:12:12 |
1 |
MN-60
Resource Report
Resource Website
|
RRID:CVCL_1421
|
Homo sapiens (Human)
|
Burkitt lymphoma
|
Virology: EBV-negative., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6296550 PMID:15843827 PMID:16408098 PMID:20164919 PMID:24590883 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35354797 PMID:35839778
|
Cancer cell line
|
Male |
MN 60, MN60 |
|
|
CLO:CLO_0007808, CLDB:cl3506, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473415, cancercelllines:CVCL_1421, Cell_Model_Passport:SIDM00438, ChEMBL-Cells:CHEMBL3308532, ChEMBL-Targets:CHEMBL2366070, Cosmic:908143, Cosmic:1012093, Cosmic-CLP:908143, DepMap:ACH-002275, DSMZ:ACC-138, DSMZCellDive:ACC-138, EGA:EGAS00001000978, GDSC:908143, GEO:GSM1670120, GEO:GSM5137727, IARC_TP53:21509, LINCS_LDP:LCL-1010, PharmacoDB:MN60_946_2019, PRIDE:PXD023662, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1421, Wikidata:Q54906259 |
|
|
CVCL_1421 |
2026-09-05 11:12:00 |
0 |
MOLT-16
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1424
|
Homo sapiens (Human)
|
Childhood T acute lymphoblastic leukemia
|
Caution: TP53 mutations indicated to be at p.Met237Arg (c.710T>G) and p.Gly244Cys (c.730G>T) (PubMed=2144611)., Population: African American., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2144611 PMID:2784121 PMID:9408752 PMID:9510473 PMID:9933131 PMID:10739008 PMID:11226526 PMID:15472075 PMID:15843827 PMID:17170727 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22675565 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35354797 PMID:35839778
|
Cancer cell line
|
Female |
Molt-16, MOLT 16, MOLT16, Molt16 |
|
|
BTO:BTO_0004173, EFO:EFO_0002239, CLDB:cl3516, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473343, BioSample:SAMN10988570, cancercelllines:CVCL_1424, Cell_Model_Passport:SIDM00431, ChEMBL-Cells:CHEMBL3308271, ChEMBL-Targets:CHEMBL2366362, Cosmic:908147, Cosmic:913425, Cosmic:919155, Cosmic:922678, Cosmic:998725, Cosmic:1115601, Cosmic:1151787, Cosmic:1226859, Cosmic:1281380, Cosmic:1330491, Cosmic:1641382, Cosmic:1760528, Cosmic:2458764, Cosmic:2462862, Cosmic:2602927, Cosmic-CLP:908147, DepMap:ACH-000918, DSMZ:ACC-29, DSMZCellDive:ACC-29, EGA:EGAS00001000978, GDSC:908147, GEO:GSM887335, GEO:GSM888411, GEO:GSM1670127, GEO:GSM5137729, IARC_TP53:187, IARC_TP53:21513, IGRhCellID:MOLT16, LiGeA:CCLE_638, LINCS_LDP:LCL-1018, Lonza:2, MetaboLights:MTBLS789, PharmacoDB:MOLT16_956_2019, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_1424, PubChem_Cell_line:CVCL_1424, Wikidata:Q54906347 |
|
|
CVCL_1424 |
2026-09-05 11:12:03 |
3 |
Mono-Mac-6
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1426
|
Homo sapiens (Human)
|
Adult acute monocytic leukemia
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3162233 PMID:7833491 PMID:8225390 PMID:14671638 PMID:15843827 PMID:16408098 PMID:20164919 PMID:22460905 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
MONO-MAC-6, Mono-mac-6, MONO-MAC 6, Mono Mac 6, Mono Mac6, MonoMac 6, MonoMac6, MONOMAC6, MM6 |
|
|
BTO:BTO_0002333, CLO:CLO_0007828, EFO:EFO_0006287, CLDB:cl3535, CLDB:cl7057, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BCRJ:0373, BioSample:SAMN03473411, BioSample:SAMN10988430, cancercelllines:CVCL_1426, Cell_Model_Passport:SIDM01023, ChEMBL-Cells:CHEMBL3308335, ChEMBL-Targets:CHEMBL2366062, CLS:305440, Cosmic:787459, Cosmic:850390, Cosmic:908148, Cosmic:975278, Cosmic:1012100, Cosmic:1089514, Cosmic:1281335, Cosmic:1465950, Cosmic:1524836, Cosmic:2131547, Cosmic:2306198, Cosmic:2392975, Cosmic-CLP:908148, DepMap:ACH-000006, DSMZ:ACC-124, DSMZCellDive:ACC-124, EGA:EGAS00001000978, GDSC:908148, GEO:GSM236795, GEO:GSM236831, GEO:GSM887338, GEO:GSM888414, GEO:GSM1374692, GEO:GSM1670130, IARC_TP53:21514, ICLC:HTL01015, LiGeA:CCLE_095, LINCS_LDP:LCL-1063, Lonza:4, PharmacoDB:MONOMAC6_960_2019, PRIDE:PXD030304, Progenetix:CVCL_1426, PubChem_Cell_line:CVCL_1426, Wikidata:Q54906378 |
|
|
CVCL_1426 |
2026-09-05 11:12:04 |
18 |
MOLT-4
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0013
|
Homo sapiens (Human)
|
Adult T acute lymphoblastic leukemia
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
|
PMID:165156 PMID:1765142 PMID:2041050 PMID:2140233 PMID:2144611 PMID:2846092 PMID:2985879 PMID:3159941 PMID:3335022 PMID:3874327 PMID:4547172 PMID:4567231 PMID:6181032 PMID:6198871 PMID:6200433 PMID:6582512 PMID:6954533 PMID:8127147 PMID:8316623 PMID:8547074 PMID:8558913 PMID:8641406 PMID:8957066 PMID:9331090 PMID:9510473 PMID:9685479 PMID:9787181 PMID:10071127 PMID:10700174 PMID:10739008 PMID:11021758 PMID:11226526 PMID:11416159 PMID:11986953 PMID:12068308 PMID:15472075 PMID:15748285 PMID:15901131 PMID:16408098 PMID:16957166 PMID:17088437 PMID:17117183 PMID:19372543 PMID:20164919 PMID:20215515 PMID:20922763 PMID:22068913 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24670534 PMID:24762992 PMID:25877200 PMID:26295583 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:28569787 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31733513 PMID:32449352 PMID:35354797 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Male |
Molt-4, MOLT 4, Molt 4, MOLT.4, MOLT4, Molt4, GM02219, GM02219C, GM2219C, GM02219D |
|
|
BTO:BTO_0000873, CLO:CLO_0007825, CLO:CLO_0032246, CLO:CLO_0050992, EFO:EFO_0001220, MCCL:MCC:0000335, CLDB:cl3524, CLDB:cl3525, CLDB:cl3527, CLDB:cl3528, CLDB:cl3529, CLDB:cl3530, CLDB:cl3531, CLDB:cl3532, CLDB:cl4976, CLDB:cl5233, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ATCC:CRL-1582, BCRC:60060, BCRJ:0176, BioSample:SAMN03470847, BioSample:SAMN03471400, BioSample:SAMN03472410, BioSample:SAMN03473319, BioSample:SAMN10988202, cancercelllines:CVCL_0013, CCRID:1101HUM-PUMC000043, CCRID:3101HUMTCHu224, CCRID:4201HUM-CCTCC00083, CCTCC:GDC0083, Cell_Model_Passport:SIDM00145, ChEMBL-Cells:CHEMBL3307557, ChEMBL-Targets:CHEMBL614177, CLS:300115, Coriell:GM02219, Cosmic:716176, Cosmic:721716, Cosmic:801730, Cosmic:850194, Cosmic:850381, Cosmic:875865, Cosmic:897451, Cosmic:905958, Cosmic:913409, Cosmic:919154, Cosmic:922677, Cosmic:932766, Cosmic:933547, Cosmic:974249, Cosmic:991545, Cosmic:999763, Cosmic:1012099, Cosmic:1019314, Cosmic:1044254, Cosmic:1070704, Cosmic:1071877, Cosmic:1082518, Cosmic:1092615, Cosmic:1115596, Cosmic:1118467, Cosmic:1127263, Cosmic:1130237, Cosmic:1151788, Cosmic:1175131, Cosmic:1175857, Cosmic:1176596, Cosmic:1226858, Cosmic:1305339, Cosmic:1312325, Cosmic:1330500, Cosmic:1483362, Cosmic:1509200, Cosmic:1524808, Cosmic:1639636, Cosmic:1664513, Cosmic:1811158, Cosmic:1998457, Cosmic:2039521, Cosmic:2165720, Cosmic:2361368, Cosmic:2560251, Cosmic:2602924, Cosmic-CLP:905958, dbMHC:48976, DepMap:ACH-001127, DSMZ:ACC-362, DSMZCellDive:ACC-362, ECACC:85011413, ECACC:94022544, EGA:EGAS00001000978, GDSC:905958, GEO:GSM2092, GEO:GSM50196, GEO:GSM50912, GEO:GSM236794, GEO:GSM236830, GEO:GSM743460, GEO:GSM750821, GEO:GSM799348, GEO:GSM799411, GEO:GSM887336, GEO:GSM888412, GEO:GSM1178423, GEO:GSM1178424, GEO:GSM1178425, GEO:GSM1181333, GEO:GSM1181349, GEO:GSM1670128, GEO:GSM1696583, GEO:GSM1696584, GEO:GSM1696585, GEO:GSM1696586, GEO:GSM2124644, GEO:GSM4471876, GEO:GSM5137731, GEO:GSM7701445, GEO:GSM7701446, IARC_TP53:27042, ICLC:HTL99025, IGRhCellID:MOLT4, IHW:IHW09226, IPD-IMGT/HLA:11094, IZSLER:BS TCL 85, JCRB:IFO50362, JCRB:JCRB9031, KCB:KCB 200940YJ, KCLB:21582, LINCS_LDP:LCL-1019, Lonza:810, NCBI_Iran:C149, NCI-DTP:MOLT-4, PharmacoDB:MOLT4_958_2019, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD018565, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_0013, PubChem_Cell_line:CVCL_0013, RCB:RCB0206, SKY/M-FISH/CGH:2741, Ubigene:YC-C127, Wikidata:Q54906365 |
|
|
CVCL_0013 |
2026-09-05 11:12:03 |
318 |